Free public webinar series presented by leading medicines policy researchers. The webinars aim to make recent, policy-relevant research more accessible to a global public audience and facilitate flows of knowledge between the research and policy & practice communities.


Past webinars (recordings and materials available on links)

Dec 2021 | Joseph Larsen, Venatorx Pharmaceuticals; Former BARDA; Daniel P. Gross, Duke University Fuqua School of Business, and National Bureau of Economic Research

Nov 2021 | Donald W. Light, Professor of comparative health policy and psychiatry, School of Osteopathic Medicine, Rowan University, Stratford; Adjunct professor in medical ethics, New York University


Contribute to improve and update this page!

We particularly welcome suggestions of topics for the webinars

Oct 2021 Gabriela Costa Chaves, Independent Researcher; Pauline Londeix, Observatoire de la Transparence dans les Politiques du Médicament (OTMeds)

June 2021 Eduardo Urias, Assistant Professor, Faculty of Science, Athena Institute, VU University Amsterdam; Danielle Navarro, Research Assistant, Global Health Centre

April 2021 | Manica Balasegaram, Executive Director, GARDP - Global Antibiotic Research and Development Partnership; Michelle Childs, Director of Policy Advocacy, DNDi - Drugs for Neglected Diseases initiative


March 2021 | Marcela Vieira, Researcher and Project Coordinator of the Knowledge Network for Innovation and Access to Medicines, Global Health Centre, IHEID

February 2021 | Monirul Azam, Associate professor in Law, Södertörn University and Adjunct faculty in Intellectual Property Law, Stockholm University; Sangeeta Shashikant, Development and Intellectual Property, Third World Network



November 2020 | Ayesha Sitlani, Associate Vice President - Antibody Strategy, International AIDS Vaccine Initiative (IAVI)


October 2020 | Julia Barnes-Weise, The Global Health Innovation Alliance Accelerator (GHIAA); Viviana Galli, European Alliance for Responsible R&D and Affordable Medicines



September 2020 | David Levine, Elon University School of Law

June 2020 | Julia Paranhos, Federal University of Rio de Janeiro; Ellen 't Hoen, Medicines Law & Policy


April 2020 | Yousuf Vawda, University of KwaZulu-Natal; Lynette Mabote, Southern African Programme on Access to Medicines and Diagnostics (SAPAM)

March 2020 | Dzintars Gotham, Independent researcher; Lindsay McKenna, Treatment Action Group (TAG)

February 2020 | Suerie Moon, Global Health Centre, Graduate Institute of Geneva; Tania Cernuschi, World Health Organization


December 2019 | Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board (PMPRB), Canada


November 2019 | Slavek Roller, Faculty of Economics and Business, Goethe University Frankfurt; Nadya Wells, Global Health Centre, Graduate Institute of Geneva


October 2019 | Peter Yu, Center for Law and Intellectual Property at Texas A&M University; Yuanqiong Hu, Access Campaign of Médecins Sans Frontières (MSF)


September 2019 | Reed Beall, University of Calgary; Mayra Vasquez,  National College of Pharmaceutical Chemists of Colombia; Miguel Cortes,  UNOPS (United Nations Office for Project Services)


June 2019 | Marg Ewen and Molly Lepeska, Health Action International

April 2019 | Ekaterina Cleary, Bentley University

March 2019 | Kiu Tay-Teo, World Health Organization

February 2019 | Carolina Gomez, INVIMA - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia’s National Institute of Food and Drug Monitoring)

January 2019 | Fred Abbott, Florida State University College of Law

December 2018 | Sabine Vogler, Austrian Public Health Institute (GÖG)

November 2018 | Gavin Yamey, Duke University

October 2018 | Achal Prabhala, accessibsa: Innovation & Access to Medicines in India, Brazil & South Africa

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.